Expert review of pharmacoeconomics & outcomes research
The economic impact, healthcare resource utilization, and clinical outcome over 24 months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- The Fidelity Study.
Georgia Kourlaba, Georgios Koutsis, Nikolaos Fakas, Vana Tsimourtou, Georgios Karachalios, Christos Bakirtzis, Nikolaos Grigoriadis
Published: 202510.1080/14737167.2025.2603955
Abstract
BACKGROUND: The review of healthcare costs in multiple sclerosis (MS) has been of increased interest. In this study, we aimed to estimate the economic burden of MS patients, treated with dimethyl fumarate (DMF) in Greece. RESEARCH DESIGN AND METHODS:…
Preview only. Read the full abstract at the source